Literature DB >> 8138062

Time courses of changes in hepatic and skeletal muscle insulin action and GLUT4 protein in skeletal muscle after STZ injection.

J H Youn1, J K Kim, T A Buchanan.   

Abstract

To determine the relative time courses of changes in peripheral and hepatic insulin action and skeletal muscle GLUT4 protein levels after a streptozotocin (STZ) injection in rats, we performed hyperinsulinemic (14-18 nM), euglycemic (7.5 mM) clamps in control (n = 8) and diabetic rats at 1 (n = 7), 3 (n = 8), 7 (n = 8), and 14 (n = 6) days after intraperitoneal STZ (65 mg/kg). Basal plasma glucose concentrations increased from 8.1 +/- 0.2 mM in control rats to 23.5 +/- 1.2 mM 1 day after STZ (P < 0.01) and remained constant thereafter. Basal plasma insulin levels were approximately 35% of control levels in all STZ groups (P < 0.01). Insulin-stimulated whole-body glucose uptake decreased significantly as early as one day after STZ injection (P < 0.01), resulting predominantly from a decrease in whole-body glycolysis. Insulin action to suppress hepatic glucose output was normal on day 1 after STZ but impaired markedly on day 3 and thereafter (P < 0.01). Insulin-stimulated glucose uptake in individual skeletal muscles was not altered until day 7 after STZ, and the magnitudes of decreases in skeletal muscle insulin action on days 7 and 14 were not fully accounted for by the decreases in GLUT4 protein level measured from the same muscles. Our data indicate that there is a temporal hierarchy in the development of insulin resistance in STZ-induced diabetes.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8138062     DOI: 10.2337/diab.43.4.564

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  18 in total

1.  Wnt signaling regulates hepatic metabolism.

Authors:  Hongjun Liu; Maria M Fergusson; J Julie Wu; Ilsa I Rovira; Jie Liu; Oksana Gavrilova; Teng Lu; Jianjun Bao; Donghe Han; Michael N Sack; Toren Finkel
Journal:  Sci Signal       Date:  2011-02-01       Impact factor: 8.192

2.  Acute cannabinoid receptor type 1 (CB1R) modulation influences insulin sensitivity by an effect outside the central nervous system in mice.

Authors:  D Song; R H J Bandsma; C Xiao; L Xi; W Shao; T Jin; G F Lewis
Journal:  Diabetologia       Date:  2011-02-22       Impact factor: 10.122

3.  Enhanced insulin sensitivity in mice lacking ganglioside GM3.

Authors:  Tadashi Yamashita; Akira Hashiramoto; Martin Haluzik; Hiroki Mizukami; Shoshannah Beck; Aaron Norton; Mari Kono; Shuichi Tsuji; Jose Luis Daniotti; Norbert Werth; Roger Sandhoff; Konrad Sandhoff; Richard L Proia
Journal:  Proc Natl Acad Sci U S A       Date:  2003-03-10       Impact factor: 11.205

4.  Role of adiponectin in the metabolic effects of cannabinoid type 1 receptor blockade in mice with diet-induced obesity.

Authors:  Joseph Tam; Grzegorz Godlewski; Brian J Earley; Liang Zhou; Tony Jourdan; Gergö Szanda; Resat Cinar; George Kunos
Journal:  Am J Physiol Endocrinol Metab       Date:  2013-12-31       Impact factor: 4.310

5.  Thiazolidinediones improve insulin sensitivity in adipose tissue and reduce the hyperlipidaemia without affecting the hyperglycaemia in a transgenic model of type 2 diabetes.

Authors:  H Kim; M Haluzik; O Gavrilova; S Yakar; J Portas; H Sun; U B Pajvani; P E Scherer; D LeRoith
Journal:  Diabetologia       Date:  2004-12-15       Impact factor: 10.122

6.  Hepatic Sirt1 deficiency in mice impairs mTorc2/Akt signaling and results in hyperglycemia, oxidative damage, and insulin resistance.

Authors:  Rui-Hong Wang; Hyun-Seok Kim; Cuiying Xiao; Xiaoling Xu; Oksana Gavrilova; Chu-Xia Deng
Journal:  J Clin Invest       Date:  2011-10-03       Impact factor: 14.808

7.  DNA-PK Promotes the Mitochondrial, Metabolic, and Physical Decline that Occurs During Aging.

Authors:  Sung-Jun Park; Oksana Gavrilova; Alexandra L Brown; Jamie E Soto; Shannon Bremner; Jeonghan Kim; Xihui Xu; Shutong Yang; Jee-Hyun Um; Lauren G Koch; Steven L Britton; Richard L Lieber; Andrew Philp; Keith Baar; Steven G Kohama; E Dale Abel; Myung K Kim; Jay H Chung
Journal:  Cell Metab       Date:  2017-05-02       Impact factor: 27.287

8.  GLP-1(7-36)amide binding in skeletal muscle membranes from streptozotocin diabetic rats.

Authors:  M L Villanueva-Peñacarrillo; E Delgado; D Vicent; E Mérida; A I Alcántara; I Valverde
Journal:  Endocrine       Date:  1995-09       Impact factor: 3.633

9.  A precision medicine approach to metabolic therapy for breast cancer in mice.

Authors:  Ngozi D Akingbesote; Aaron Norman; Wanling Zhu; Alexandra A Halberstam; Xinyi Zhang; Julia Foldi; Maryam B Lustberg; Rachel J Perry
Journal:  Commun Biol       Date:  2022-05-20

10.  Mechanisms and time course of impaired skeletal muscle glucose transport activity in streptozocin diabetic rats.

Authors:  R Napoli; M F Hirshman; E S Horton
Journal:  J Clin Invest       Date:  1995-07       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.